Literature DB >> 23551588

The role of spreading depolarization in subarachnoid hemorrhage.

R Sánchez-Porras1, Z Zheng, E Santos, M Schöll, A W Unterberg, O W Sakowitz.   

Abstract

Subarachnoid hemorrhage (SAH) is a devastating disease associated with death and poor functional outcome. Despite decades of intense research and improvements in clinical management, delayed cerebral ischaemia (DCI) remains the most important cause of morbidity and mortality after SAH. The key role of angiographic cerebral vasospasm, thought to be the main cause of DCI, has been questioned. Emerging evidence suggests that DCI is likely to have a multifactorial etiology. Over the last few years, spreading depolarization (SD) has been identified as a potential pathophysiological mechanism contributing to DCI. The presence of cortical spreading ischaemia, due to an inverse hemodynamic response to SD, offers a possible explanation for DCI and requires more intensive research. Understanding the role of SD as another mechanism inducing DCI and its relationship with other pathological factors could instigate the development of new approaches to the diagnosis and treatment of DCI in order to improve the clinical outcome.
© 2013 The Author(s) European Journal of Neurology © 2013 EFNS.

Entities:  

Keywords:  delayed cerebral ischaemia; spreading depolarization; spreading ischaemia; subarachnoid hemorrhage

Mesh:

Year:  2013        PMID: 23551588     DOI: 10.1111/ene.12139

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  8 in total

Review 1.  Noninvasive Neuromonitoring: Current Utility in Subarachnoid Hemorrhage, Traumatic Brain Injury, and Stroke.

Authors:  Luisa Vinciguerra; Julian Bösel
Journal:  Neurocrit Care       Date:  2017-08       Impact factor: 3.210

2.  Controversies and evolving new mechanisms in subarachnoid hemorrhage.

Authors:  Sheng Chen; Hua Feng; Prativa Sherchan; Damon Klebe; Gang Zhao; Xiaochuan Sun; Jianmin Zhang; Jiping Tang; John H Zhang
Journal:  Prog Neurobiol       Date:  2013-09-25       Impact factor: 11.685

3.  Epileptiform abnormalities predict delayed cerebral ischemia in subarachnoid hemorrhage.

Authors:  J A Kim; E S Rosenthal; S Biswal; S Zafar; A V Shenoy; K L O'Connor; S C Bechek; J Valdery Moura; M M Shafi; A B Patel; S S Cash; M B Westover
Journal:  Clin Neurophysiol       Date:  2017-01-29       Impact factor: 3.708

4.  Soluble ST2 Is Associated With New Epileptiform Abnormalities Following Nontraumatic Subarachnoid Hemorrhage.

Authors:  W Taylor Kimberly; Eric S Rosenthal; India A Lissak; Sahar F Zafar; M Brandon Westover; Riana L Schleicher; Jennifer A Kim; Thabele Leslie-Mazwi; Christopher J Stapleton; Aman B Patel
Journal:  Stroke       Date:  2020-03-11       Impact factor: 7.914

Review 5.  Delayed Cerebral Ischemia after Subarachnoid Hemorrhage: Beyond Vasospasm and Towards a Multifactorial Pathophysiology.

Authors:  Joseph R Geraghty; Fernando D Testai
Journal:  Curr Atheroscler Rep       Date:  2017-10-23       Impact factor: 5.113

Review 6.  The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice.

Authors:  Gargi Banerjee; Roxana Carare; Charlotte Cordonnier; Steven M Greenberg; Julie A Schneider; Eric E Smith; Mark van Buchem; Jeroen van der Grond; Marcel M Verbeek; David J Werring
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-08-26       Impact factor: 10.154

Review 7.  Understanding Spreading Depression from Headache to Sudden Unexpected Death.

Authors:  Olga Cozzolino; Maria Marchese; Francesco Trovato; Enrico Pracucci; Gian Michele Ratto; Maria Gabriella Buzzi; Federico Sicca; Filippo M Santorelli
Journal:  Front Neurol       Date:  2018-02-01       Impact factor: 4.003

Review 8.  Monitoring in Neurointensive Care - The Challenge to Detect Delayed Cerebral Ischemia in High-Grade Aneurysmal SAH.

Authors:  Asita S Sarrafzadeh; Peter Vajkoczy; Philippe Bijlenga; Karl Schaller
Journal:  Front Neurol       Date:  2014-07-21       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.